Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology.
Offit K, Bradbury A, Storm C, et al.
J Clin Oncol. 2013 Jun 13. [Epub ahead of print]
Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma.
Fox E, Widemann BC, Chuk MK, et al.
Clin Cancer Res. 2013 Jun 13. [Epub ahead of print]
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
McConechy MK, Ding J, Senz J, et al.
Mod Pathol. 2013 Jun 14. [Epub ahead of print]
Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses.
Wheler J, Hong D, Swisher SG, et al.
Oncotarget. 2013 Jun 10. [Epub ahead of print]
Anti-tumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers.
Saito K, Takigawa N, Ohtani N, et al.
Mol Cancer Ther. 2013 Jun 12. [Epub ahead of print]
Pancreatic Cancer Genomes: Toward Molecular Subtyping and Novel Approaches to Diagnosis and Therapy.
Wood LD.
Mol Diagn Ther. 2013 Jun 12. [Epub ahead of print]
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.
Cooper WA, Yu B, Yip PY, et al.
J Clin Pathol. 2013 Jun 11. [Epub ahead of print]
Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.
Lianidou ES, Mavroudis D, Georgoulias V.
Br J Cancer. Jun 11. [Epub ahead of print]
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy.
Glück S, de Snoo F, Peeters J, et al.
Breast Cancer Res Treat. 2013 Jun 12. [Epub ahead of print]
Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.
Janzen DM, Rosales MA, Paik DY, et al.
Cancer Res. 2013 Jun 6. [Epub ahead of print]
Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas.
Acs G, Kiluk J, Loftus L, Laronga C.
Mod Pathol. 2013 Jun 7. [Epub ahead of print]
Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
Nikiforova MN, Khalid A, Fasanella KE, et al.
Mod Pathol. 2013 Jun 7. [Epub ahead of print]
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.
Selinger CI, Rogers TM, Russell PA, et al.
Mod Pathol. 2013 Jun 7. [Epub ahead of print]
Evaluation of ALK Rearrangement in Chinese Non-Small Cell Lung Cancer Using FISH, Immunohistochemistry, and Real-Time Quantitative RT- PCR on Paraffin-Embedded Tissues.
Zhang YG, Jin ML, Li L, et al.
PLoS One. 2013 May 31;8(5):e64821.
HER2 and Breast Cancer Stem Cells: More than Meets the Eye.
Korkaya H, Wicha MS.
Cancer Res. 2013 Jun 15;73(12):3489-93.
Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T, Fabbri C, Bentini F, Serretti A.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 1. [Epub ahead of print]
Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T, Fabbri C, Bentini F, Serretti A.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 1. [Epub ahead of print]